Photo from wikipedia
Metronidazole is the preferred empirical anti‐anaerobic agent for patients with suspected anaerobic infection. The balance between benefits and harms of empirical metronidazole is unclear. We aimed to assess patient‐important benefits… Click to show full abstract
Metronidazole is the preferred empirical anti‐anaerobic agent for patients with suspected anaerobic infection. The balance between benefits and harms of empirical metronidazole is unclear. We aimed to assess patient‐important benefits and harms of empirical metronidazole vs placebo/no treatment in adult patients with severe bacterial infection of any origin.
Keywords:
bacterial infection;
patients severe;
empirical metronidazole;
analysis;
severe bacterial
Journal Title: Acta Anaesthesiologica Scandinavica
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Anaesthesiologica Scandinavica
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!